Search

1. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final policy recommendations

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 11, 2021

Subject(s):

Immunoconjugates
Immunotherapy, Adoptive
Multiple Myeloma
United States

2. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018

Subject(s):

Immunotherapy, Adoptive
Leukemia, B-Cell -- drug therapy
Lymphoma, B-Cell -- drug therapy
Lymphoma, Non-Hodgkin -- drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
United States

3. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final report

Author(s):

Lee, Sei J., author
Beinfeld, Molly, author
Fluetsch, Noemi, author
Whittington, Melanie, D., author
Pearson, Steven D., author
Ollendorf, Daniel A., author
McQueen, R. Brett, author
Gutierrez, Eric, (Of University of Colorado Anschutz Medical Campus), author
Kwon, Sue, (Of University of Colorado Anschutz Medical Campus), author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 22, 2022

Subject(s):

Immunoconjugates -- therapeutic use
Immunotherapy, Adoptive
Multiple Myeloma -- drug therapy
United States